Showing 1511-1520 of 1576 results for "".
- Tom Frinzi to Retire; Warren Foust Appointed President of J&J Vision Surgicalhttps://modernod.com/news/tom-frinzi-to-retire-from-johnson-replaced-by-warren-foust/2477156/Johnson & Johnson Vision announced that Warren Foust will assume the role of Worldwide President, Surgical for Johnson & Johnson Vision, effective December 2. Mr. Foust replaces Tom Frinzi, who will retire at the end of 2019 after a 35-year career in ophthalmology. Mr. Frinzi was
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- Valeda Light Delivery System Receives 2019 Medical Design Excellence Awardhttps://modernod.com/news/valeda-light-delivery-system-receives-2019-medical-design-excellence-award/2476654/LumiThera and Product Creation Studio announced that LumiThera’s Valeda Light Delivery System has won a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2
- Pharmaceutical Executives Field Questions at US Senate Hearing Over Drug Pricinghttps://modernod.com/news/pharmaceutical-executives-field-questions-at-us-senate-hearing-over-drug-pricing/2476258/CEOs and senior executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson appeared before the US Senate Finance Committee on Tuesday to testify about the high cost of drugs in the country. The executives, who continued to blame pharmacy
- Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with J&J’s Janssenhttps://modernod.com/news/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration-with-jjs-janssen/2476272/Morphic Therapeutic announced that it has entered into a research and development collaboration with Johnson & Johnson’s subsidiary Janssen Biotech, to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson &a
- Janssen Enters License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseaseshttps://modernod.com/news/janssen-enters-license-agreement-with-meiragtx-to-develop-gene-therapy-programs-for-inherited-retinal-diseases/2476340/The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings, a clinical-stage gene therapy company, to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio, including leadin
- US House Oversight Committee Launches Investigation into Prescription Drug Pricinghttps://modernod.com/news/us-house-oversight-committee-launches-investigation-into-prescription-drug-pricing/2476191/The US House of Representatives’ Oversight Committee on Monday announced a probe into a dozen pharmaceutical companies regarding drug pricing. In the investigation, Representative and committee chairman Elijah Cummings sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson
- Two Studies Measure Performance of Acuvue Oasys with Transitions Light Intelligent Technology Contact Lenseshttps://modernod.com/news/two-studies-measure-performance-of-acuvue-oasys-with-transitions-light-intelligent-technology-contact-lenses/2479693/Johnson & Johnson Vision announced that data from two new studies on the visual effects of photochromic contact lenses were presented at the 2018 American Academy of Optometry Annual Meeting in San Antonio. These are the first scientific presentations focused on photochromic contact lens tech
- The Retina Group of Washington Will Merge With Maryland’s Retina Associateshttps://modernod.com/news/the-retina-group-of-washington-will-merge-with-marylands-retina-associates/2479714/The Retina Group of Washington (RGW), a leading provider of retinal and macular care in the Washington, D.C., metropolitan area, has announced plans to merge with Retina Associates (RA), a 5-office practice operating in suburban Maryland locations, according to a
- J&J Vision Introduces Artificial-Intelligence Powered Virtual Assistant for Contact Lenseshttps://modernod.com/news/jj-vision-introduces-artificial-intelligence-powered-virtual-assistant-for-contact-lenses/2480195/Johnson & Johnson Vision introduced Andy, a virtual assistant chatbot powered by artificial intelligence (AI). Andy is designed to help guide U.S. consumers throughout their Acuvue brand contact lens journey – from those considering contact lenses for the first time to long-term wearers. The